Screening for hepatitis C

JAMA - Journal of the American Medical Association

Volumn 313, Issue 18, 2015, Pages 1855-1856

  Wray, Charlie M ^a   Davis, Andrew M ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BOCEPREVIR; PEGINTERFERON; RIBAVIRIN; TELAPREVIR; HEPATITIS C ANTIBODY;

ANTIBODY DETECTION; ANXIETY; AREA UNDER THE CURVE; BLOOD ANALYSIS; CHILDBIRTH; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EVIDENCE BASED MEDICINE; FATIGUE; FLU LIKE SYNDROME; GENOTYPE; HEADACHE; HEMATOLOGIC DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ABUSE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL DECISION MAKING; MEDICAL RESEARCH; NON INVASIVE PROCEDURE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECEIVER OPERATING CHARACTERISTIC; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING; SHORT SURVEY; SOCIAL STIGMA; SYMPTOM; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; TREATMENT RESPONSE; BLOOD; HEPACIVIRUS; MASS SCREENING;

HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC;

EID: 84929431250     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.2833     Document Type: Short Survey

References (9)

1. World Health Organization. Guidelines for the Screening, Care and Treatment of Persons With Hepatitis C Infection. Geneva, Switzerland: World Health Organization; April 2014.
2. Moyer VA; US Preventive Services Task Force. Screening for hepatitis C virus infection in adults. Ann Intern Med. 2013;159(5):349-357.
3. Ward JW. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States. Clin Liver Dis. 2013;17(1):1-11.
4. Chou R, Cottrell EB, Wasson N, Rahman B, Guise J. Screening for hepatitis C virus infection in adults: a systematic review for the US Preventive Services Task Force.Ann Intern Med. 2013;158(2):101-108.
5. Chou R, Bougatsos C, Blazina I, et al. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs. Rockville, MD: Agency for Healthcare Research and Quality; January 2013.
6. Rein DB, Smith BD, Wittenborn JS, et al. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in US primary care settings. Ann Intern Med. 2012;156(4):263-270.
7. Myers RP, Ratziu V, Imbert-Bismut F, et al. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol. 2002;97(9):2419-2425.
8. McGowan CE, Fried MW. Barriers to hepatitis C treatment.Liver Int. 2012;32(suppl 1):151-156.
9. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep.2012;61 (RR-4):1-32.